4.6 Article

Mitotic entry: The interplay between Cdk1, Plk1 and Bora

Journal

CELL CYCLE
Volume 15, Issue 23, Pages 3177-3182

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15384101.2016.1249544

Keywords

Bora; Plk1 activation; Cdk1; FRET

Categories

Funding

  1. Miguel Servet Program from the Instituto Carlos III - European Regional Development Fund (ERDF) [CP13/00158]
  2. VHIR PhD fellowship
  3. Foundation for Medical Research
  4. French National Research Agency [ANR-2012-BSV2-0001-01]
  5. Foundation for Medical Research [Equipe FRM DEQ20140329538]
  6. University of Geneva
  7. Swiss National Science Foundation [31003A_156013]
  8. NCCR Chemical Biology
  9. Instituto Carlos III [PI15/02238, RTC-2015-3821-1]
  10. Swiss National Science Foundation (SNF) [31003A_156013] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Polo-like kinase 1 (Plk1) is an important mitotic kinase that is crucial for entry into mitosis after recovery from DNA damage-induced cell cycle arrest. Plk1 activation is promoted by the conserved protein Bora (SPAT-1 in C. elegans), which stimulates the phosphorylation of a conserved residue in the activation loop by the Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1 contributes to Plk1 activation through SPAT-1/Bora phosphorylation. We identified 3 conserved Sp/Tp residues that are located in the N-terminal, most conserved part, of SPAT-1/Bora. Phosphorylation of these sites by Cdk1 is essential for Plk1 function in mitotic entry in C. elegans embryos and during DNA damage checkpoint recovery in mammalian cells. Here, using an untargeted Forster Resonance Energy Transfer (FRET) biosensor to monitor Plk1 activation, we provide additional experimental evidence supporting the importance of these phosphorylation sites for Plk1 activation and subsequent mitotic entry after DNA damage. We also briefly discuss the mechanism of Plk1 activation and the potential role of Bora phosphorylation by Cdk1 in this process. As Plk1 is overexpressed in cancer cells and this correlates with poor prognosis, understanding how Bora contributes to Plk1 activation is paramount for the development of innovative therapeutical approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available